136 related articles for article (PubMed ID: 22413119)
1. First description of the role of ¹⁸F-FDG-PET/CT as compared to CT, MRI to suspect a case of thymoma in a pediatric patient.
Tsuchida T; Kinoshita S; Kawakita A; Yasutomi M; Tanizawa A; Kimura H
Hell J Nucl Med; 2012; 15(1):68-9. PubMed ID: 22413119
[No Abstract] [Full Text] [Related]
2. Clinical use of combined positron emission tomography and computed tomography in thymoma recurrence.
El-Bawab HY; Abouzied MM; Rafay MA; Hajjar WM; Saleh WM; Alkattan KM
Interact Cardiovasc Thorac Surg; 2010 Oct; 11(4):395-9. PubMed ID: 20639307
[TBL] [Abstract][Full Text] [Related]
3. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
[TBL] [Abstract][Full Text] [Related]
5. Thymoma and immunodeficiency: (18)F-FDG-PET/CT imaging of Good syndrome.
Kelly A; Merlin C; Trouillier S; Cachin F; Guettrot-Imbert G
Hell J Nucl Med; 2013; 16(2):140-1. PubMed ID: 23687646
[No Abstract] [Full Text] [Related]
6. Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging.
Chong EA; Torigian DA; Mato AR; Downs LH; Schuster SJ
Clin Nucl Med; 2008 Oct; 33(10):692-3. PubMed ID: 18806570
[No Abstract] [Full Text] [Related]
7. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
8. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
9. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
10. Incidental early stage endometrial adenocarcinoma diagnosed by F-18 FDG PET-CT, which was negative on ultrasound and nonspecific on MRI.
Makis W; Abikhzer G; Stern J
Clin Nucl Med; 2010 Apr; 35(4):265-6. PubMed ID: 20305418
[No Abstract] [Full Text] [Related]
11. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
[TBL] [Abstract][Full Text] [Related]
12. A unique presentation of appendicitis: F-18 FDG PET/CT.
Koff SG; Sterbis JR; Davison JM; Montilla-Soler JL
Clin Nucl Med; 2006 Nov; 31(11):704-6. PubMed ID: 17053390
[TBL] [Abstract][Full Text] [Related]
13. Combined (18)F-FDG and fluoride approach in PET/CT imaging: is there a clinical future?
Basu S; Rao R
J Nucl Med; 2010 Jan; 51(1):165; author reply 166-7. PubMed ID: 20008984
[No Abstract] [Full Text] [Related]
14. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
[TBL] [Abstract][Full Text] [Related]
15. Fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging of uterine leiomyosarcomas: 2 cases report.
Zhang HJ; Zhan FH; Li YJ; Sun HR; Bai RJ; Gao S
Chin Med J (Engl); 2011 Jul; 124(14):2237-40. PubMed ID: 21933635
[TBL] [Abstract][Full Text] [Related]
16. Multi-technique imaging of sarcoidosis.
Balan A; Hoey ET; Sheerin F; Lakkaraju A; Chowdhury FU
Clin Radiol; 2010 Sep; 65(9):750-60. PubMed ID: 20696303
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
Tateishi U; Hosono A; Makimoto A; Nakamoto Y; Kaneta T; Fukuda H; Murakami K; Terauchi T; Suga T; Inoue T; Kim EE
Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET provides the best correlation with the tumor specimen compared to MRI and CT in rectal cancer.
Buijsen J; van den Bogaard J; Janssen MH; Bakers FC; Engelsman S; Öllers M; Beets-Tan RG; Nap M; Beets GL; Lambin P; Lammering G
Radiother Oncol; 2011 Feb; 98(2):270-6. PubMed ID: 21295874
[TBL] [Abstract][Full Text] [Related]
19. F-18 FDG PET evaluation of bronchial plasmacytoma with CT and MRI correlation.
Iagaru A; Mari C; Segall G
Clin Nucl Med; 2006 May; 31(5):279-80. PubMed ID: 16622337
[No Abstract] [Full Text] [Related]
20. Detection of thyroid plasmacytoma by F-18 FDG PET/CT imaging.
Ozkan E; Tokmak E; Kir KM
Clin Nucl Med; 2008 Apr; 33(4):292-3. PubMed ID: 18356675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
